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Erratum
This Erratum to our article [1] aims at making our
randomization procedure more explicit, because our
article did not explain the procedure in an appropriate
manner, which could be misleading for future meta-
analysis, and more generally for the readers. Moreover,
this procedure can be of interest for clinicians who
want to test two treatments of common practice.
Indeed, the comparison of the GH and [GH + anastra-
zole] treatments was based on the randomization of
patients’ files to be analyzed, not on randomization of
treatments themselves, as could be felt when reading
our publication. Thus no treatment was dictated by
randomization.
To perform our study, we randomly allocated a list of
ordered numbers to treatment by GH or [GH+ anastrazole].
For example, number 1 would be GH, number 2 [GH+
anastrazole], number 3 [GH+ anastrazole], number 4 GH,
etc. This list kept by the PI was concealed to the physicians
in charge of the patients. Children with very short stature
who came in our clinic were simply given a number from 1
to 50 per order of arrival at the clinic. The choice of the
clinicians in charge for using GH alone or [GH+ anastrazole]
was not influenced by these numbers. The use of anastrazole
was inspired by publications showing a delay of epiphyseal
maturation with this product.
At time of analysis, we used the numbers to retrieve
only the patients’ files where randomly allocated treat-
ment matched the treatment that had been actually
decided by their doctor. In many cases, files did not
match and were thus not used for the comparison,
whereas the matching files allowed us to perform the ran-
domized comparison. This original method allowed the
study to combine the advantages of randomization while
remaining entirely observational, and is best suited for
comparing two treatments of current practice.
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